Status:

COMPLETED

A Comparative Effectiveness RCT of Optimized Cessation Treatments

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

Penn State University

University of Illinois at Chicago

Conditions:

Smoking Cessation

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Ces...

Detailed Description

The ultimate goal of this research is to develop a chronic care treatment package for smokers that will address the challenges and opportunities of each phase of the cessation process - motivation, pr...

Eligibility Criteria

Inclusion

  • age \>=18 years
  • smoking \>4 cigarettes/day for the previous 6 months
  • able to read, write, and speak English
  • have reliable phone access and agree to respond to Interactive Voice Response (IVR) phone prompts
  • and if currently using NRT, agreeing to use only study medication for the duration of the study
  • we will not exclude participants based on their prior use of cessation medication or if they use multiple tobacco products in order to enhance real-world generalization (these will be statistically controlled in analyses)
  • not currently attempting to quit smoking
  • not intending to quit smoking (defined as no plans to quit in the next month)
  • and planning to remain in the intervention catchment area for at least 12 months.

Exclusion

  • currently taking bupropion or varenicline
  • medical contraindications to using NRT including hospitalized (for at least one night) for a stroke, heart attack, congestive heart failure or diabetes in the last 30 days
  • diagnosis of or treatment for schizophrenia, a psychotic disorder or bipolar disorder in the last 10 years
  • and, if the participant is a woman of childbearing potential, being pregnant or intending to becoming pregnant or unwillingness to use an approved method of birth control during treatment.

Key Trial Info

Start Date :

January 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2018

Estimated Enrollment :

623 Patients enrolled

Trial Details

Trial ID

NCT02301403

Start Date

January 1 2015

End Date

February 1 2018

Last Update

May 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health

Madison, Wisconsin, United States, 53711